Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

Fig. 2

LS mean (SE) change from baseline (left panel) and treatment difference (right panel, exenatide twice daily − glimepiride) in systolic blood pressure (a), diastolic blood pressure (b), and heart rate (c) in randomized patients. bpm beats per minute, BID twice daily, DBP diastolic blood pressure, HR heart rate, LS least-squares, SBP systolic blood pressure, SE standard error

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840